News | January 29, 2007

Intraoperative MRI in Operation at Pediatric Hospital

January 30, 2007 - Cook Children's Medical Center will soon house the combined IMRIS Intraoperative MRI (iMRI) operating room/diagnostic room, enabling surgeons to view high-resolution patient scans during brain surgery leading to improved patient
outcomes.
"Cook Children's pediatric neuroscience department annually cares for
approximately 16,000 children, making the program one of the largest in the
Southwest," said David Donahue, M.D., director of Neurosurgery, Cook Children's Medical Center. "The addition of the iMRI demonstrates the institution's commitment to the care of neurological and neurosurgical disorders."
The iMRI will occupy a two-room suite allowing the 1.5 Tesla MRI magnet,
suspended from tracks in the ceiling, to glide in and out of the operating
room. The system provides surgeons with exquisite digital images of the brain
during surgery. Surgeons can employ computer-guided software to better
determine the location, size, and often complex shape of a brain tumor, as
well as a distinction between the tumor and healthy tissue.
When the magnet is not being used in surgery, it reportedly can move to the adjacent diagnostic imaging suite where neuroscientists can perform complex functional and anatomic imaging. This will be especially beneficial to Cook Children's epilepsy patients, extending the diagnostic power of the Epilepsy Monitoring Unit.
"The most common uses for the iMRI system at Cook Children's will involve
surgical treatment of epilepsy and resection of brain tumors," said Donahue.
"In the latter application, intraoperative images provided by the iMRI allow
surgeons to detect and remove residual tumors which may not be readily apparent, even to the experienced eye; surgery can continue until all the tumor has in fact been removed, avoiding another trip to the operating room."
The iMRI is scheduled to be operational in February and is part of a $9.7 million suite that will treat children with epilepsy, brain tumors, hydrocephalus and other neurological problems.

Related Content

This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...